baber/WOPTO huggingface dataset:
Patent FI-930654-A0 (FI)
Inventor: PEDERSEN SVEN
IPC: C12N9/96
Filed: 1993-02-15
Abstract: PCT No. PCT/DK91/00222 Sec. 371 Date Feb. 1, 1993 Sec. 102(e) Date Feb. 1, 1993 PCT Filed Aug. 9, 1991 PCT Pub. No. WO92/03543 PCT Pub. Date Mar. 5, 1992.The ALDC derivative is produced by treating ALDC in an aqueous medium with glutaraldehyde in defined proportions with optional subsequent immobilization. The ALDC derivative which is used in beer fermentation exhibits a satisfactory stability at low pH.
Patent FI-934418-A0 (FI)
Inventor: GRAHN BENGT
IPC: E04H15/24
Filed: 1993-10-07
Abstract: PCT No. PCT/SE92/00209 Sec. 371 Date Apr. 4, 1994 Sec. 102(e) Date Apr. 4, 1994 PCT Filed Apr. 2, 1992 PCT Pub. No. WO92/18729 PCT Pub. Date Oct. 29, 1992.A substantially cone-shaped tent comprises a plurality of rods connected to each other in the region of the top of the tent and arranged to extend divergingly downwardly to the ground on which the tent stands and bear thereagainst while each forming substantially a generatrix of an imagined cone, a substantially cone-shaped tent cloth adapted to bear on the outside of and be carried by the rods, and means adapted to interconnect adjacent rods at a distance from the top of the tent so as to hold them in a determined mutual position. Said interconnecting means comprise elongated rigid elements with a first engaging member at each end thereof, and the rods have second engaging members arranged to enter into engagement with the first engaging members arranged on the corresponding rigid elements when connecting adjacent rods by means of the rigid elements and by that hold two adjacent rods at a mutual distance defined by the rigid element.
Patent FI-954033-A0 (FI)
Inventor: DAHRINGER JOERG
IPC: D01F6/92
Filed: 1995-08-28
Abstract: A non-woven fabric of electret fibres is predominantly made of a fibre-forming polymer or polycondensate and 0.01-30, pref. 0.01-10, and esp. 0.1-5, wt.% of an organic or organometallic charge control agent. The fabric contains ≥ 2 sorts of electret fibres which are made from different materials. Also claims dust filters and dust wiping cloth made from the non-woven fabric; and the use of the non-woven fabric in fire dust filters and in dust wiping cloths.
Patent FI-955738-A0 (FI)
Inventor: MELBY JEFFREY A
IPC: E02B3/04
Filed: 1995-11-28
Abstract: A concrete armor or erosion prevention module for the protection of river, lake, and reservoir banks, shorelines and other structures is characterized by a central elongate concrete member and two outer elongate concrete members connected on opposites sides of the central member. The outer members have parallel longitudinal axes extending normal to the longitudinal axis of the central member. These elongate members all have an octagonal cross-section and are further configured such that their cross-sectional area decreases from an intermediate portion towards opposite ends thereof. A plurality of the modules may be interlocked to form a cohesive array or barrier which protects shorelines and other structure from erosive hydrodynamic forces.
Patent AP-9701040-A0 (AP)
Title: Novel compounds.
Inventor: HINKS JEREMY DAVID
IPC: C07C311/39
Filed: 1997-07-03
Abstract: Compounds of formula (1a)and pharmaceutically acceptable salts and derivativews thereof in which y is a carbamoyloxy group, in which the n-atom is unsubstituted, or mono- or di-substituted, are useful in the treatment of bacterial infections.
Patent IL-72253-A0 (IL)
Title: Method and apparatus for the determination of substances included in cells
IPC: G01N33/483
Filed: 1984-06-28
Abstract: Disclosed is a process and device for determining which cells of a suspension containing cells of the same species and genus are secreting cellular substances. Such determinations are made by exposing the cells to rotating electrical field forces of variable rotational speed and differentiating the cells secreting the cellular substances from the other cells by means of their rotational behavior which differs from that of the other cells.
Patent IL-73958-A0 (IL)
Title: Contrast agents and method of use thereof
IPC: A61K/
Filed: 1984-12-27
Abstract: Contrast agents comprising aqueous emulsions or mixtures of iophendylate and their use in radiological examination of the small and large intestine after oral administration.
Patent IL-75277-A0 (IL)
Title: Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
IPC: C07K16/00
Filed: 1985-05-22
Abstract: Transformed human lymphocyte cell lines have been produced which secrete human monoclonal antibodies to serotypic determinants on LPS molecules of gram-negative bacteria. These antibodies have been found to be protective against lethal challenges of the homologous bacteria. Pharmaceutical compositions containing these antibodies and their prophylactic and therapeutic use in the management of gram-negative disease in humans are also disclosed.Humam lymphocyte cell lines secreting human monoclonal antibodies specifically reacting with Pseudomonas aeruginosa Fisher immunotypes 1 (C5B7), 2(6F11), 4 (G5D5), 5 (13C1 6 (5G2) and 7 (8E7) were deposited at the American Type Culture Collection and given A.T.C.C. Accession Nos. CRL 8753, CRL 8562, CRL 8754, CRL 8796, CRL 8797 and CRL 8795, respectively.
Patent IL-76798-A0 (IL)
Title: Apparatus for mounting on a land vehicle for the distribution of markers
IPC: B65G59/06
Filed: 1985-10-23
Abstract: The self-erecting markers (5), each comprising a base plate and a marker member hinged thereto and spring-biased to upright position, are stacked folded flat in preferably two holder-shafts provided in the dispensing apparatus (2) designed for attachment to a vehicle (1), e.g. a mine-clearing vehicle. 
<??>Alternate gravity-delivery from the two shafts of one marker at a time is controlled by a common dispensing mechanism comprising two vertically spaced, interlocked double-scissors arrangements; drive of the dispensing mechanism is controlled from within the vehicle. 
<??>The markers are stacked angularly staggered, and the upper double-scissors arrangement is adapted upon closing to bend the top part of the marker members, causing activation of light emission.
Patent IL-88456-A0 (IL)
Title: Contact lenses for animals and method of fabrication
IPC: A01K29/00
Filed: 1988-11-23
Abstract: A contact lens for an animal having a nictitating membrane has a curved central region (12) and a peripheral region (14) of opposite curvature having an annular surface region (15) which contacts the eye tissue to support the lens.
Patent IL-89276-A0 (IL)
Title: Human relaxin formulation
IPC: A61P15/00
Filed: 1989-02-14
Abstract: A pharmaceutical composition is provided wherein human relaxin is formulated at an acidic pH of about 4 to less than about 7. The composition, useful for effecting parturition and inhibiting premature delivery, includes a buffer capable of maintaining the pH of the composition within a desired range, and may also include an agent to make the composition isotonic, and a stabilizing agent, if necessary. A specific example is human relaxin formulated in a citrate buffer, pH about 5.0, in the presence of sodium chloride, at an ionic strength of about 0.15  mu .
Patent IL-96360-A0 (IL)
Title: Process for the preparation of 1-(aminomethyl)cyclohexaneacetic acid
IPC: C07C253/30
Filed: 1990-11-15
Abstract: There is described a novel process for preparing 1-(aminomethyl)cyclohexaneacetic acid, a drug used as anticonvulsive. 
<??>To this end, a dialkyl (1-cyanocyclohexyl)malonate is decarbalkoxylated to give the corresponding alkyl (1-cyanocyclohexyl)acetate, then transesterified with a benzyl alcohol and finally hydrogenated to give the end product. 
<??>Benzyl (1-cyanocyclohexyl)acetates can also be obtained by reacting (1-cyanocyclohexyl)acetonitrile with a benzyl alcohol in the presence of a mineral acid, followed by hydrolysis with water. 
<??>Alkyl (1-cyanocyclohexyl)acetates can also be obtained by reacting (1-cyanocyclohexyl)acetonitrile with a lower aliphatic alcohol in the presence of a mineral acid, followed by hydrolysis with water.
Patent IL-99021-A0 (IL)
Title: Low-vulnerability explosive munitions element
IPC: F42B3/11
Filed: 1991-07-31
Abstract: A relatively insensitive component of explosive ammunition consisting of a casing containing a multicomposition explosive charge in which the innermost layer is a composite explosive consisting of a filled polyurethane or polyester polymeric matrix in which the filler contains more than 40 % by weight of organic nitro explosive and in which the peripheral layer is a pyrotechnic composition of the class of composite solid propellants, consisting of a filled polyurethane or polyester polymeric matrix in which the filler contains at least one inorganic oxidiser and less than 10 % by weight of organic nitro explosives. The blast and/or bubble effect produced is close to that produced by the much more sensitive charge of a single-composition composite explosive of equivalent mass. 
<??>The invention also relates to a process for obtaining a blast and/or bubble effect by release of gas in the casing of an abovementioned component of ammunition according to the invention followed by a rupture of the casing. The gas release is obtained by detonation of the innermost layer followed by a detonation-free reaction of the peripheral layer.
Patent AU-PQ653000-A0 (AU)
Title: Perfusion incubator
IPC: C12M3/02
Filed: 2000-03-28
Abstract: A perfusion incubator having a fluid conditioning unit (12), a well assembly (7) and a well assembly heating unit (14), a peristaltic pump (4) and a fluid collection unit (11). The well assembly has a number of wells (20, 21) each having a transparent lid (30) and a fluid inlet (26) and a fluid outlet (27). An illumination device (13) is under the well so that the cell being cultured in the well assembly can be observed by means of a microscope (15). Each fluid inlet (26) is positioned so as to allow a tangential entry of fluid to the well at a mid point in the well, and each fluid outlet (27) is above the fluid inlet with the cell to be cultured in a lower portion of the well so that flow of fluid in the well is formed into a vortex which tends to draw fluid from around the cell without direct flow over the embryo.
Patent FI-20002060-A0 (FI)
Inventor: LINDQVIST ANSSI
IPC: H04W76/00
Filed: 2000-09-18
Abstract: The invention relates to a method and device for setting up and setting down a data-communication link in a telecommunication system. In the method, a connection is established between a first terminal device (MS1) and a second terminal device (MS2) via the service point of the intelligent network (IN), and a connection is established between a first Internet terminal device (IDTE1) and a second Internet terminal device (IDTE2) via a connection server (CS). In the method, a connection is further established from the first terminal device (MS1) to the second terminal device (MS2) by means of the identifier of the service and the subscriber number of the second terminal device (MS2), the connection card is saved to the data-base (DB) of the service point of the intelligent network (IN), and a connection is established between the first (IDTE1) and the second Internet terminal device (IDTE2), if there is in the connection card of the database (DB) an approval for the connection set-up.
Patent FI-20010970-A0 (FI)
Inventor: PIKULINSKY KAJ
IPC: C10M173/02
Filed: 2001-05-09
Abstract: The present invention relates to the use of a water based fluid composition as a hydraulic fluid. The fluid composition is particularly suitable for conditions with temperatures lower than 0 DEG C. The fluid composition comprises from 1 to 60% by weight of trimethyl glycine or salts of a trimethyl glycine hydrate or derivativesof trimethyl glycine or mixtures thereof, from 40 to 99% by weight of water and optionally additives.
Patent FI-20021740-A0 (FI)
Inventor: SIHVOLA JOUNI KALEVI
IPC: A23L29/238
Filed: 2002-10-01
Abstract: A process for the preparation of a nutritive preparation based on vegetable matter, which nutritive preparation includes vegetable cutlets, balls, nuggets, loaves and kebabs, includes turning process textured soy protein flakes, psyllium husk powder, liquid and extra ingredient/s optionally chosen from among flour, spices, herbs and non-animal broth concentrate into a mixture by warming the mixture at an elevated temperature, after which pieces of desired shape are prepared from the substance and they are fried by heat. A nutritive preparation based on vegetable matter contains textured soy protein flakes, psyllium husk powder, liquid and extra ingredient/s optionally chosen from among flour, spices, herbs and non-animal broth concentrates is also described.
Patent IL-113639-A0 (IL)
Title: Sunscreen compounds
IPC: A61Q17/04
Filed: 1995-05-07
Abstract: The present invention relates to compounds which are useful as sunscreens. The compounds persist on the skin for much longer than conventional sunscreens because they comprise a Michael acceptor linked directly or indirectly to a chromophore. The Michael acceptor is capable of undergoing a conjugate addition reaction with thiol groups present in cysteine residues of keratin and thus the compound is chemically bound to the skin and will not be removed by immersion in water.
Patent IL-126395-A0 (IL)
Title: Inhibitor and stimulator of stem cell proliferation and uses thereof
IPC: C07K14/52
Filed: 1997-04-03
Abstract: Disclosed and claimed are methods for the isolation and use of stem cell modulating factors for regulating stem cell cycle and for accelerating the post-chemotherapy peripheral blood cell recovery. Also disclosed and claimed are the inhibitors and stimulators of stem cell proliferation.
Patent IL-128036-A0 (IL)
Title: Deoxynojirimycin derivatives and their uses as glucosylceramidase inhibitors
IPC: A61K31/445
Filed: 1997-07-14
Abstract: Deoxynojirimycin derivatives containing a large hydrophobic moiety, such as cholesterol or adamantame-methanol, linked through a spacer, such as pentamethylene, to the nitrogen atom of deoxynojirimycin, and salts thereof, inhibit glucosylceramidase and may be useful in the treatment of diseases involving a ceramide-mediated signaling process, such as Gaucher disease.
Patent IL-130827-A0 (IL)
Title: Heregulin variants
IPC: C12P21/02
Filed: 1998-02-10
Abstract: The present invention provides heregulin variants that are capable of binding an ErbB receptor. Included in the invention are variants of human heregulins, and, in particular, variants of human heregulin-beta1 having enhanced affinity for the ErbB-3 and ErbB-4 receptors. These variants include at least one amino acid substitution and can include further modifications. The invention also provides nucleic acid molecules encoding heregulin variants and related vectors, host cells, pharmaceutical compositions, and methods.
Patent IL-131021-A0 (IL)
Title: Multiple site delivery of adenoviral vector for the induction of angiogenesis
IPC: A61P9/10
Filed: 1998-01-29
Abstract: The present invention provides a method for enhancing the level of perfusion of blood to a target tissue, treating a target tissue suffering from or at risk of suffering from ischemic damage, inducing angiogenesis in a target tissue, and/or inducing collateral blood vessel formation in a target tissue affected by or at risk of being affected by a vascular occlusion. The present inventive method comprises administering to the target tissue a dose of a pharmaceutical composition comprising (a) a pharmaceutically acceptable carrier and (b) an adenoviral vector comprising a DNA encoding an angiogenic peptide, such that the level of perfusion of blood to the target tissue is enhanced, the dose has a therapeutic or prophylactic effect on the target tissue, angiogenesis is induced in the target tissue, and/or the adenoviral vector contacts a region including the source, the terminus, and an area therebetween for the collateral blood vessel formation, and collateral blood vessel formation is induced.
Patent IL-135704-A0 (IL)
Title: Wnt -1 induced secreted polypeptides: wisp-1, -2 and -3
IPC: C07K14/47
Filed: 1998-10-29
Abstract: Wnt-l-Induced Secreted Proteins (WISPs) are provided, whose genes are induced at least by Wnt-1. Also provided are nucleic acid molecules encoding those polypeptides, as well as vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides, and methods for producing the polypeptides.
Patent IL-138330-A0 (IL)
Title: Polynucleotides, polypeptides and pharmaceutical compositions for treating lung cancer
IPC: G01N33/53
Filed: 1999-03-17
Abstract: Compounds and methods for the treatment and diagnosis of lung cancer are provided. The inventive compounds include polypeptides containing at least a portion of a lung tumor protein. Vaccines and pharmaceutical compositions for immunotherapy of lung cancer comprising such polypeptides, or DNA molecules encoding such polypeptides, are also provided, together with DNA molecules for preparing the inventive polypeptides.
Patent IL-141045-A0 (IL)
Title: A delivery system for an oral care substance using a permanently deformable strip of material
IPC: A61K8/00
Filed: 1998-08-04
Abstract: A delivery system for an oral care substance includes a strip of material having a yield point and thickness such that the strip of material substantially conforms to a shape of a tooth via permanent deformation under a pressure less than about 250,000 Pascals when the delivery system is placed thereagainst. The delivery system also includes an oral care substance applied to the strip of material such that when the delivery system is placed on a surface of the tooth, the substance contacts the surface providing an active onto the surface. The substance also provides adhesive attachment between the strip of material and the surface to hold the delivery system in place for a sufficient time to allow the active to act upon the surface. The substance has an extrusion resistance sufficient to withstand a normal force applied to deform the strip of material so that the substance is not substantially extruded from between the strip of material and the surface during manual deformation of the strip of material. A method of delivery includes pre-coating the strip of material, having the wearer apply substance to the strip of material, or having the wearer apply the substance directly to the surface before applying a strip of material.
Patent IL-141061-A0 (IL)
Title: Bpc-1 a secreted brain specific protein expressed and sectreted by prostate and bladder cancer cells
IPC: C12P21/08
Filed: 1999-08-10
Abstract: Described is a novel gene and its encoded secreted tumor antigen, termed BPC-1, and to diagnostic and therapeutic methods and compositions useful in the management of various cancers which express BPC-1, particularly including prostate cancer and bladder cancer. In human normal tissues, BPC-1 is only expressed in certain tissues of the brain. However, BPC-1 is expressed at high levels in prostate cancer cells and is also expressed in bladder cancer cells. The structure of BPC-1 includes a signal sequence and a CUB domain. BPC-1 protein is secreted. Preliminary experimental evidence suggests that BPC-1 is directly involved in oncogenesis or maintenance of the transformed phenotype of cancer cells expressing BPC-1. BPC-1 also appears to bind specifically to a cellular protein expressed in prostate cancer cells and other cells.
Patent IL-142088-A0 (IL)
Title: Methods and compositions for inhibiting neoplastic cell growth
IPC: A61K45/06
Filed: 1999-10-05
Abstract: The present invention concerns methods and compositions for inhibiting neoplastic cell growth. In particular, the present invention concerns antitumor compositions and methods for the treatment of tumors. The invention further concerns screening methods for identifying growth inhibitory, e.g., antitumor compounds.
Patent IL-148186-A0 (IL)
Title: Motor fuel for diesel, gas-turbine and turbojet engines, comprising at least four different oxygen-containing functional groups selected from alcohol, ether, aldehyde, ketone, ester, inorganic ester, acetal, epoxide and peroxide
IPC: C10L1/185
Filed: 2000-09-06
Abstract: A motor fuel comprises hydrocarbon compounds and/or organic compounds containing bound oxygen, which constitutes a stable homogeneous liquid at atmospheric pressure and normal ambient temperature and achieves a reduction of harmful pollutants in the exhaust emissions of diesel engines by adding organic compounds containing bound oxygen to the fuel composition.  A motor fuel comprises hydrocarbon compounds and/or organic compounds containing bound oxygen, which constitutes a stable homogeneous liquid at atmospheric pressure and normal ambient temperature and achieves a reduction of harmful pollutants in the exhaust emissions of diesel engines by adding organic compounds containing oxygen bound in the following functional groups: -O-H, -O-, -C(O)=O, -O-NO2, -C(H)=O, -O-O-, -C(O)-O- to the fuel composition.
Patent IL-155988-A0 (IL)
Title: A nuclear magnetic resonance method for screening compounds in order to identify ligands that bind to a specific target molecule
IPC: G01N33/53
Filed: 1996-11-13
Abstract: A method for designing and forming a ligand which binds to a specific target molecule comprises the steps of: (a) identifying a first ligand moiety that binds to the target molecule using two-dimensional <15>N/<1>H NMR correlation spectroscopy; (b) identifying subsequent ligand moieties that bind to the target molecule using two-dimensional <15>N/<1>H NMR correlation spectroscopy; (c) forming a complex of the first and subsequent ligand moieties to the target molecule; (d) determining the three-dimensional structure of the complex and, thus, the spatial orientation of the first and subsequent ligand moieties on the target molecule; and (e) linking the first and subsequent ligand moieties to form a new ligand to maintain the spatial orientation of the ligand moieties. <IMAGE>
Patent IL-156218-A0 (IL)
Title: Method for identifying compounds modulating reverse cholesterol transport
IPC: C12N1/21
Filed: 2002-02-04
Abstract: The present invention concerns methods and compounds capable of modulating reverse cholesterol transport in a mammal and screening methods for selecting, identifying and/or characterizing compounds capable of modulating reverse cholesterol transport. It also concerns cells, vectors and genetic constructs used for implementing said methods, and pharmaceutical compositions for treating atherosclerosis. The methods of the invention are based on the use of FXR response elements derived from the apo A-I gene promoter.
Patent IL-169179-A0 (IL)
Title: Device for automated coupling between a micro-chromatograph and a mass spectrometer comprising temperature adjustment
IPC: G01N30/72
Filed: 2005-06-15
Abstract: In an apparatus for coupling a chromatograph and a mass spectrometer (8), in a tube leaving the chromatograph (1), a pressure sensor (18) sends a signal to a control unit (12) of a temperature control system.
Patent IL-169191-A0 (IL)
Title: Novel process for preparing a 5 - hydroxy - 3 - oxo - hexanoic acid derivative
IPC: C07C69/716
Filed: 2005-06-15
Abstract: The present invention is related to a novel process for preparing an optically active 5-hydroxy-3-oxo-hexanoic acid derivative or its tautomer which is useful intermediate for preparing statins such as atorvastatin and rosuvastatin. Blaise reaction of (S)-4-halo-3-hydroxybutyronitrile with -haloacetate is utilized as a key reaction to provide the product with minimal formation of side products and in good yield.